Oxford Biodynamics signs an extension of its Collaboration Agreement with a major Japanese Pharmaceutical Company under which Oxford Biodynamics Pte Limited, a wholly owned subsidiary of Oxford Biodynamics based in Singapore, to conduct an extended non-invasive test for breast cancer using Japanese samples.